Stem cells as screening tools in drug discovery

Current Opinion in Pharmacology

Volumn 7, Issue 5, 2007, Pages 515-520

  McNeish, John D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; GLUTAMATE RECEPTOR AGONIST; GLYCOGEN SYNTHASE KINASE 3; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NOTCH RECEPTOR; PROTEIN KINASE B; PROTEIN P53; ROLIPRAM; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SONIC HEDGEHOG PROTEIN; WNT PROTEIN;

CACHEXIA; CELL DIFFERENTIATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; ENZYME INACTIVATION; GENE FUNCTION; HIGH THROUGHPUT SCREENING; HUMAN; MESENCHYMAL STEM CELL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL DIFFERENTIATION; DRUG DESIGN; HUMANS; STEM CELLS;

EID: 35248884308     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2007.06.005     Document Type: Review

References (36)

1. Dresch C., Poirier O., Mine J., and Bismuth C. Effect of different sedative drugs on the proliferation of bone marrow cells. Eur J Toxicol Environ Hyg 8 (1975) 252-257
2. Gordon M.Y., and Blackett N. The sensitivities of human and murine hematopoietic cells exposed to cytotoxic drugs in an in vivo culture system. Cancer Res 36 (1976) 2822-2826
3. Salmon S.E., Hamburger A.W., Soehnlen B., Durie B.G., Alberts D.S., and Moon T.E. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. New Engl J Med 298 (1978) 1321-1327
4. Doetschman T.C., Eistetter H., Katz M., Schmidt W., and Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87 (1985) 27-45
5. McNeish J. Embryonic stem cells in drug discovery. Nat Rev Drug Disc 3 (2004) 70-80
6. Allen M., Svensson L., Roach M., Hambor J., McNeish J., and Gabel C. Deficiency of the stress kinase p38a results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 191 (2000) 859-869
7. Schwarzkopf M., Coletti D., Sassoon D., and Marazzi G. Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway. Genes Dev 20 (2007) 3440-3452
8. Barko B.Z., Song H., Aimone J.B., Smrt R.D., Kuwabara T., Nakashima K., Gage F.H., and Zhao Z. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells Dev 15 (2006) 407-421. This article is an innovative approach to evaluating the role of secreted and membrane-bound intracellular signaling between astrocytes and neuronal precursors in neuronal differentiation. This gain-of-function evaluation with candidate gene products yields functional evidence that supports a role of inflammatory cytokines and chemokines in stem cell regeneration.
9. Gnecchi M., He H., Liang O.D., Melo L.G., Morello F., Mu H., Noiseux N., Zhang L., Pratt R.E., Ingwall J.S., and Dzau V.J. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11 (2005) 367-368
10. Mirotsou M., Zhang Z., Deb A., Zhang L., Gnecchi M., Noiseux N., Mu H., Pachori A., and Dzau V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-releasing paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci 104 (2007) 1643-1648. This article reports a very clever application of stem cells using coculture conditions to define specific paracrine factors that mediate myocardial survival and repair in models of ischemia.
11. Ivanova N., Dobrin R., Lu R., Kotenko I., Levorse J., DeCoste C., Schafer X., Lun Y., and Lemiscka I.R. Dissecting self-renewal in stem cells with RNA interference. Nature 442 (2006) 533-538. This article reports an excellent application of high-throughout RNAi-based screening. The authors demonstrate the power of combining stem cells and RNAi mutagenesis to generate hypothesis from hundreds of factors potentially involved in stem cell self renewal and further test the hypothesis in candidate genes.
12. Paddison P.J., Silva J.M., Conklin D.S., Schlabach M., Li M., Aruleba S., Balija V., O'Shaughnessy A., Gnoj L., Scobie K., et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
13. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124 (2006) 1283-1298
14. Yang J.P., Fan W., Rogers C., Chatterton J.E., Bliesath J., Liu G., Ke N., Wang C.Y., Rhoades K., Wong-Staal F., and Li Q.X. A novel RNAi library based on partially randomized consensus sequences of nuclear receptors: identifying the receptors involved in amyloid beta degradation. Genomics 88 (2006) 282-292
15. Martin S.E., Jones T.L., Thomas C.L., Lorenzi P.L., Nguyen D.A., Runfola T., Gunsior M., Weinstein J.N., Goldsmith P.K., Lader E., et al. Multiplexing siRNA's to compress RNAi-based screen size in human cells. Nucl Acids Res 35 (2007) e57
16. Bushway P.J., and Mercola M. High-throughput screening for modulators of stem cell differentiation. Meth Enzymol 414 (2006) 300-316. This article is an excellent review for investigators planning to develop high-throughput screening in stem cells or cell types derived from stem cells. Methods reported here could be applied to numerous screening applications in stem cell-based assays.
17. Sager R., and Kovac P. Pre-adipocyte determination either by insulin or by 5-azacytidine. Proc Natl Acad Sci 79 (1982) 480-484
18. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103 (1984) 285-293
19. Ding S., and Schultz P.G. A role for chemistry in stem cell biology. Nat Biotech 22 (2004) 833-840
20. Ding S., and Schultz P.G. Small molecules and future regenerative medicine. Curr Top Med Chem 5 (2005) 383-395. This article is a recent review of several important publications by the Scripps Research Institute team of Peter Schultz and Sheng Ding. This review describes their efforts in small molecule based approaches to stem cell self-renewal, regeneration, and differentiation. This article is an excellent resource for those considering the new opportunities stem cells may provide in discovering new pathways or potential therapeutics in regenerative medicine.
21. Ding S., Wu T.Y., Brinker A., Peters E.C., Hur W., Gray N.S., and Schultz P.G. Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci 100 (2003) 7632-7637
22. Kola I., and Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Disc 3 (2004) 711-715
23. Chaudhary K.W., Barrazueta N.X., Bauchmann M.B., Milici A.J., Beckius G., Stedman D.B., Hambor J.E., Blake W.L., McNeish J.D., Bahinski A., and Cezar G.G. Embryonic stem cells in predictive cardiotoxicity: laser capture microscopy enables assay development. Toxicol Sci 90 (2006) 149-158
24. Norstrom A., Akesson K., Hardarson T., Hamberger L., Bjorquist P., and Sartipy P. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med 231 (2006) 1753-1762. This article is a demonstration of predictive pharmacologic properties in human ES derived cardiomyocytes.
25. Genschow E., Spielman H., Scholz G., Pohl I., Seiler A., Clemann N., Bremer S., and Becker K. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 33 (2004) 209-244
26. Chapin R., Stedman D., Paquette J., Streck R., Kumpf S., and Deng S. Struggles for equivalence: in vitro developmental toxicity model evolution in pharmaceuticals in 2006. Toxicol In Vitro (2006) 10.1016/j.tiv.2006.10.006
27. Seiler A., Visan A., Buesen R., Genschow E., and Spielmann H. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod Toxicol 18 (2004) 231-240
28. Zwaka T.P., and Thomson J.A. Homologous recombination in human embryonic stem cells. Nat Biotechnol 21 (2003) 319-321
29. Ulloa-Montoya F., Verfaillie C.M., and Hu W.S. Culture systems for pluripotent stem cells. J Biosci Bioeng 100 (2005) 12-27
30. Neuman B., Held M., Liebel U., Erfle H., Rogers P., Pepperkok R., and Ellenberg J. High-throughput RNAi screening by time-lapse imaging of live human cells. Nat Meth 3 (2006) 385-390
31. Paran Y., Lavelin I., Naffar-Abu-Amara S., Winograd-Katz S., Liron Y., Geiger B., and Kam Z. Development and application of automatic high-resolution light microscopy for cell-based screens. Meth Enzymol 414 (2006) 228-247
32. Aboody K.S., Bush R.A., Garcia E., Metz M.Z., Najbauer J., Justus K.A., Phelps D.A., Remack J.S., Yoon K.J., Gillespie S., et al. Development of a tumor-selective approach to treat metastatic cancer. PLoS One (2006) 1 10.1371/journal.pone.0000023. This article is an interesting example of novel application of stem cells in drug delivery. This paper describes the trophic ability of neural stem cells to seek out cancer cells in vivo. Additionally, these investigators engineered the stem cells to activate prodrug specifically at tumor site and demonstrate excellent efficacy in cancer model.
33. Nakagawa S., Kim J.E., Lee R., Malberg J.S., Chen J., Steffen C., Zhang Y.J., Nestler E.J., and Duman R.S. Regulation of neurogenesis in adult mouse hippocampus by cAMP response element-binding protein. J Neurosci 22 (2002) 3673-3682
34. Hori Y., Rulifson I.C., Tsai B.C., Heit J.J., Cahoy J.D., and Kim S.K. Growths inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci 99 (2002) 16105-16110
35. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J Am Chem Soc 124 (2002) 14520-14521
36. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126 (2004) 1590-1591